6505--Ketoconazole 2% Cream
ID: 36E79724R0032Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/92b0cd475d3a41e7b4cfd73514764fc4/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ketoconazole 2% Cream, which will serve various federal healthcare services, including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The procurement aims to ensure an uninterrupted supply of this pharmaceutical product, with a contract period of one year and four optional one-year extensions. The estimated annual requirements include approximately 62,643 tubes of 15 GM, 233,385 tubes of 30 GM, and 139,890 tubes of 60 GM. Interested vendors should note that the solicitation is expected to be released around October 10, 2024, with a response deadline of October 24, 2024, and can direct inquiries to Michael Olszewski at michael.olszewski@va.gov.

    Point(s) of Contact
    708-786-4966Michael Olszewski
    (708) 786-4966
    michael.olszewski@va.gov
    Files
    Title
    Posted
    36E79724R0032_1.docx
    The Department of Veterans Affairs (VA) National Acquisition Center plans to issue Request for Proposal (RFP) 36E79724R0032 for the procurement of Ketoconazole 2% Cream, intended for various federal healthcare services, including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The solicitation is scheduled for release around October 10, 2024, with a response deadline of October 24, 2024. The contract will cover one year with four optional one-year extensions, with a focus on maintaining an uninterrupted supply of the drug. Interested vendors must provide specific product naming and unique NDC numbers. Estimated annual requirements include approximately 62,643 tubes of 15 GM, 233,385 tubes of 30 GM, and 139,890 tubes of 60 GM. Detailed updates and potential amendments will be available electronically on www.beta.sam.gov, and no physical documents will be distributed. Questions regarding the solicitation can be directed to the designated contact, Michael Olszewski, via email.
    Lifecycle
    Title
    Type
    6505--Ketoconazole 2% Cream
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Calcitonin Gene-Related Peptides (CGRP) to support various healthcare programs, including those for Consolidated Mail Order Pharmacies and State Veterans Homes. The contract will require the successful offeror to provide a consistent supply of specified CGRP products, which are critical for treating patients with certain medical conditions, ensuring uninterrupted access to these essential medications. The solicitation is expected to be released on or about October 10, 2024, with a closing date of October 24, 2024, and interested parties should direct inquiries to Contracting Officer Chris Carthron at Christopher.Carthron@va.gov or by phone at (708) 786-4980. The contract will span one year with four additional one-year options, and all relevant documents will be available electronically at sam.gov.
    Tretinoin Cream
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Tretinoin Cream. The cream is used for various dermatological conditions and comes in different strengths (0.025%, 0.05%, and 0.1%) and tube sizes (20G and 45G). The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. It will establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The annual usage estimates will be provided in the solicitation. Interested parties should contact Ryan Ferry for more information. The projected solicitation date is February 2023.
    6505--Prasugrel HCL 5mg and 10mg 30 Count Bottles
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Prasugrel Hydrochloride (HCL) tablets in 5mg and 10mg 30-count bottles. The Request for Proposal (RFP) outlines specific requirements for offerors, including pricing for a base year and four optional one-year periods, compliance with federal regulations, and the provision of unique National Drug Code (NDC) numbers. This procurement is crucial for ensuring a reliable supply of essential medications to support veterans and related healthcare providers under the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. Interested parties must submit their proposals by October 8, 2024, at 2:30 PM Central Standard Time, and can direct inquiries to Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov.
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking suppliers for Norethindrone 5mg Tablets under solicitation number VA-25-00005551. This procurement aims to secure pharmaceutical products essential for the healthcare of veterans, specifically focusing on the manufacturing of these tablets. Norethindrone is a critical medication used in various treatments, highlighting the importance of reliable supply in supporting veteran health services. Interested vendors should note that the offer due date has been extended to October 15, 2024, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    R706--Reverse pharmaceutical distribution services. Questions and Answers for solicitation RFQ 36C26024Q0959 clarification Amendment 0001
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide reverse pharmaceutical distribution services under solicitation RFQ 36C26024Q0959. The primary objective of this procurement is to ensure the safe and compliant disposal of pharmaceutical products, including the management of liquidation-eligible and ineligible items, while adhering to federal regulations. This contract, valued at approximately $16.5 million, will span five years from November 1, 2024, to October 31, 2029, with responses due by October 10, 2024, at 13:00 Pacific Time. Interested vendors should direct inquiries to José Ronstadt at jose.ronstadt@va.gov or call 360-852-9885 for further clarification.
    6505-- Duplex Antibiotic Supply IV Bags
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting quotes for Duplex Antibiotic Supply IV Bags under solicitation number 36C26225Q0028, aiming to establish a base contract for one year with four additional option years. The procurement requires the successful contractor to supply specific pharmaceutical products, including Cefazolin and Ceftriaxone, ensuring that all items meet the specified performance and regulatory standards. This contract is crucial for maintaining essential supplies for patient care within the VA healthcare system, with an estimated total contract value ranging from $150,000 to $300,000. Interested vendors must be registered in the System for Award Management (SAM) and submit any questions via email to Melissa Ramirez by October 8, 2024, with quotes due by October 11, 2024.
    6505--770-24-4-801-0686 -National CMOP CLINDAMYCIN -(VA-24-00096153)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This procurement aims to secure approximately 3,584 units of the specified pharmaceutical product, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). The goods are essential for the VA's healthcare services, supporting the treatment of various medical conditions. Interested vendors must submit their quotations by September 6, 2024, including a signed SF1449 cover page, a price schedule, proof of a valid State Wholesale Distributor License, and a Buy American Act Certificate. For further inquiries, vendors can contact Kelley Cunningham at kelley.cunningham@va.gov or call 913-684-0140.
    6505--Bupropion Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the procurement of Bupropion Hydrochloride tablets to support veterans and related entities through its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing that includes a 0.5% Cost Recovery Fee and provide unique National Drug Code (NDC) numbers for their products, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and FDA regulations. This procurement is crucial for maintaining a reliable pharmaceutical supply for VA healthcare facilities, with a strong emphasis on participation from small and disadvantaged businesses. Interested parties should contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further details regarding submission requirements and deadlines.
    6550--VA Northern California Health Care System, Mather Radiopharmaceuticals & Radiopharmaceutical Supplies
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the provision of radiopharmaceuticals and related supplies for the VA Northern California Health Care System, with a contract period spanning from April 1, 2025, to March 31, 2030. The procurement includes the delivery of various diagnostic and therapeutic radiopharmaceuticals, which are critical for effective healthcare services, particularly for veterans requiring advanced medical treatments. Contractors must comply with regulatory standards from the Nuclear Regulatory Commission and the Food and Drug Administration, ensuring quality control and timely delivery, especially for emergency services, with a minimum guaranteed contract value of $100 and a maximum of $2.5 million for total orders. Interested parties should submit their questions in writing by October 14, 2024, and direct their inquiries to Contract Specialist Tawnya S Krommenhoek at tawnya.krommenhoek@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0014 770-24-4-801-0617 -National CMOP A1222 ACAMPROSATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking to procure Acamprosate Calcium 333mg EC tablets through an emergency solicitation, identified by the number 36C77025Q0014, for delivery to multiple locations within its Consolidated Mail Outpatient Pharmacy (CMOP) system. The procurement requires various quantities of the specified pharmaceutical, with a total of six different delivery amounts outlined, and adherence to the Drug Supply Chain Security Act is mandatory for all vendors. This acquisition is critical for ensuring that the VA can meet its pharmaceutical needs efficiently, supporting the health and well-being of veterans. Interested vendors must submit their quotes by October 10, 2024, at 9:00 AM CST, and are encouraged to contact Contracting Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov for further details.